Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma

AIM: To monitor the prognosis of patients with lacrimal gland pleomorphic adenoma (LGPA) following surgical resection within the past 10y. The factors affecting patient prognosis are analyzed and the experience of surgical treatment is summarized. METHODS: In this retrospective, comparative case ser...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rui Liu, Nan Wang, Hong Zhang, Xin Ge, Jian-Min Ma
Formato: article
Lenguaje:EN
Publicado: Press of International Journal of Ophthalmology (IJO PRESS) 2021
Materias:
Acceso en línea:https://doaj.org/article/f77fbd50e42945d68851b1382aba23c4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f77fbd50e42945d68851b1382aba23c4
record_format dspace
spelling oai:doaj.org-article:f77fbd50e42945d68851b1382aba23c42021-11-26T04:02:12ZClinical analysis of 109 cases of lacrimal gland pleomorphic adenoma2222-39592227-489810.18240/ijo.2021.12.07https://doaj.org/article/f77fbd50e42945d68851b1382aba23c42021-12-01T00:00:00Zhttp://ies.ijo.cn/en_publish/2021/12/20211207.pdfhttps://doaj.org/toc/2222-3959https://doaj.org/toc/2227-4898AIM: To monitor the prognosis of patients with lacrimal gland pleomorphic adenoma (LGPA) following surgical resection within the past 10y. The factors affecting patient prognosis are analyzed and the experience of surgical treatment is summarized. METHODS: In this retrospective, comparative case series, clinical records from 109 cases of LGPA treated chiefly at the same institution between November 2009 and May 2019 were reviewed. All 109 patients underwent surgery, histopathological examination, and imaging examination. For patients who underwent surgery for the first time, LGPA could be resected completely, including tumor and capsule tissues, using a surgical approach via the eyebrow arch or double eyelid crease. RESULTS: The ratio of males to females was 1:1.60, the ages ranged from 19 to 74 years old with a mean age of 43.64±13.07 years old, and the ratio of left to right eyes was 1:1.37. A total of 109 patients underwent surgical excision and five of these received radiotherapy after malignant transformation. Of these patients, 15 were lost to follow up within the April 1, 2020 deadline and 1 was diagnosed as a recurring pathology. The 5-year recurrence rate for 86 patients who underwent initial surgery was 7.27%. Single factor analysis revealed that the course of disease, bone destruction, invasion of surrounding tissues, tumor size, capsule integrity, and expression of Ki-67 were statistically significant (P<0.05). Binomial Logistic regression analysis showed that capsule integrity was a risk factor influencing recurrence (P=0.008). CONCLUSION: LGPA has a risk of recurrence and potential for malignant transformation. Complete removal of the tumor and capsule in the initial surgery is a key factor in preventing recurrence.Rui LiuNan WangHong ZhangXin GeJian-Min MaPress of International Journal of Ophthalmology (IJO PRESS)articlepleomorphic adenomalacrimal glandmalignant transformationtreatmentprognosisOphthalmologyRE1-994ENInternational Journal of Ophthalmology, Vol 14, Iss 12, Pp 1852-1857 (2021)
institution DOAJ
collection DOAJ
language EN
topic pleomorphic adenoma
lacrimal gland
malignant transformation
treatment
prognosis
Ophthalmology
RE1-994
spellingShingle pleomorphic adenoma
lacrimal gland
malignant transformation
treatment
prognosis
Ophthalmology
RE1-994
Rui Liu
Nan Wang
Hong Zhang
Xin Ge
Jian-Min Ma
Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
description AIM: To monitor the prognosis of patients with lacrimal gland pleomorphic adenoma (LGPA) following surgical resection within the past 10y. The factors affecting patient prognosis are analyzed and the experience of surgical treatment is summarized. METHODS: In this retrospective, comparative case series, clinical records from 109 cases of LGPA treated chiefly at the same institution between November 2009 and May 2019 were reviewed. All 109 patients underwent surgery, histopathological examination, and imaging examination. For patients who underwent surgery for the first time, LGPA could be resected completely, including tumor and capsule tissues, using a surgical approach via the eyebrow arch or double eyelid crease. RESULTS: The ratio of males to females was 1:1.60, the ages ranged from 19 to 74 years old with a mean age of 43.64±13.07 years old, and the ratio of left to right eyes was 1:1.37. A total of 109 patients underwent surgical excision and five of these received radiotherapy after malignant transformation. Of these patients, 15 were lost to follow up within the April 1, 2020 deadline and 1 was diagnosed as a recurring pathology. The 5-year recurrence rate for 86 patients who underwent initial surgery was 7.27%. Single factor analysis revealed that the course of disease, bone destruction, invasion of surrounding tissues, tumor size, capsule integrity, and expression of Ki-67 were statistically significant (P<0.05). Binomial Logistic regression analysis showed that capsule integrity was a risk factor influencing recurrence (P=0.008). CONCLUSION: LGPA has a risk of recurrence and potential for malignant transformation. Complete removal of the tumor and capsule in the initial surgery is a key factor in preventing recurrence.
format article
author Rui Liu
Nan Wang
Hong Zhang
Xin Ge
Jian-Min Ma
author_facet Rui Liu
Nan Wang
Hong Zhang
Xin Ge
Jian-Min Ma
author_sort Rui Liu
title Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
title_short Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
title_full Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
title_fullStr Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
title_full_unstemmed Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
title_sort clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma
publisher Press of International Journal of Ophthalmology (IJO PRESS)
publishDate 2021
url https://doaj.org/article/f77fbd50e42945d68851b1382aba23c4
work_keys_str_mv AT ruiliu clinicalanalysisof109casesoflacrimalglandpleomorphicadenoma
AT nanwang clinicalanalysisof109casesoflacrimalglandpleomorphicadenoma
AT hongzhang clinicalanalysisof109casesoflacrimalglandpleomorphicadenoma
AT xinge clinicalanalysisof109casesoflacrimalglandpleomorphicadenoma
AT jianminma clinicalanalysisof109casesoflacrimalglandpleomorphicadenoma
_version_ 1718409941258076160